The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among the elderly, drugmaker AstraZeneca said
The COVID-19 vaccine being developed by the University of Oxford produces an immune response in both older and younger adults, and adverse responses were lower among the elderly, British drug maker AstraZeneca said
Oxford COVID-19 vaccine prompts immune response among adults old and young, AstraZeneca says via Reuters
Vaccine hopes rise as Oxford jab prompts immune response among old as well as young adults | Article [AMP] | Reuters
Vaccine hopes rise as Oxford jab prompts immune response among old as well as young adults